Gosebruch Henry O
SEC insider (Form 3/4/5 filer). CIK 0001659625. Director at ANI PHARMACEUTICALS INC (ANIP) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 19, 2026. Located in PRINCETON, NJ.
Companies Gosebruch Henry O has filed insider reports for
- ANI PHARMACEUTICALS INC (ANIP): Director
- ACELYRIN, Inc. (SLRN): Director
Gosebruch Henry O
CIK: 0001659625
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
